Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114964) titled 'Development and Clinical Translational Research of an Early Screening System for Lung Cancer-Associated Gene Methylation Based on Electrochemical-Surface Plasmon Resonance (ESPR) Technology' on Dec. 19, 2025.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Beijing Hospital
Condition:
Lung cancer
Intervention:
Gold Standard:Pathological diagnosis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Target condition:386;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chict...